Cite
HARVARD Citation
Cybulska-Stopa, B. et al. (2022). Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma. Journal of dermatological treatment. pp. 2168-2174. [Online].